APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalation CDMO

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Inhalation CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

24 December 2025194 pages

Choose your research edition.

Industry ResearchInhalation CDMO Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation CDMO Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Inhalation CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation CDMO Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation CDMO Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Inhalation CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Inhalation CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhalation CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalation CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Inhalation CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhalation CDMO include Aptar Pharma, Bend Bioscience, Bespak, Catalent, CritiTech, Enteris Biopharma, Experic, HCmed and Hovione, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Inhalation CDMO market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhalation CDMO and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhalation CDMO revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Inhalation CDMO market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhalation CDMO Segment by Company

Aptar Pharma

Bend Bioscience

Bespak

Catalent

CritiTech

Enteris Biopharma

Experic

HCmed

Hovione

Iconovo

Kindeva

Lonza

Particle Sciences

Proveris

Recipharm

Renejix

Ritedose

Vectura

Sanner

Inhalation CDMO Segment by Type

Soft Mist Inhalers (SMIs)

Dry Powder Inhalers (DPIs)

Metered Dose Inhalers (MDIs)

Others

Inhalation CDMO Segment by Application

Commercial

Academic Research

Others

Inhalation CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Inhalation CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Inhalation CDMO industry.

Chapter 3: Detailed analysis of Inhalation CDMO companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inhalation CDMOrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Inhalation CDMO Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Soft Mist Inhalers (SMIs) Table 3. Key Players of Dry Powder Inhalers (DPIs) Table 4. Key Players of Metered Dose Inhalers (MDIs) Table 3. Key Players of Others Table 4. Global Inhalation CDMO Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Commercial Table 6. Key Players of Academic Research Table 7. Key Players of Others Table 8. Global Inhalation CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Inhalation CDMO Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Inhalation CDMO Market Share by Region (2021-2026) Table 11. Global Inhalation CDMO Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Inhalation CDMO Market Share by Region (2027-2032) Table 13. Inhalation CDMO Industry Trends Table 14. Inhalation CDMO Industry Drivers Table 15. Inhalation CDMO Industry Opportunities and Challenges Table 16. Inhalation CDMO Industry Restraints Table 17. Global Inhalation CDMO Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Inhalation CDMO Revenue Market Share by Company (2021-2026) Table 19. Global Inhalation CDMO Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Inhalation CDMO Key Company Head Office and Area Served Table 21. Global Inhalation CDMO Company, Product Type & Application Table 22. Global Inhalation CDMO Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Inhalation CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Inhalation CDMO Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Inhalation CDMO Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Inhalation CDMO Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Inhalation CDMO Revenue Market Share by Type (2021-2026) Table 29. Global Inhalation CDMO Revenue Market Share by Type (2027-2032) Table 30. Global Inhalation CDMO Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Inhalation CDMO Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Inhalation CDMO Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Inhalation CDMO Revenue Market Share by Application (2021-2026) Table 34. Global Inhalation CDMO Revenue Market Share by Application (2027-2032) Table 35. Aptar Pharma Company Information Table 36. Aptar Pharma Business Overview Table 37. Aptar Pharma Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Aptar Pharma Inhalation CDMO Product Portfolio Table 39. Aptar Pharma Recent Development Table 40. Bend Bioscience Company Information Table 41. Bend Bioscience Business Overview Table 42. Bend Bioscience Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Bend Bioscience Inhalation CDMO Product Portfolio Table 44. Bend Bioscience Recent Development Table 45. Bespak Company Information Table 46. Bespak Business Overview Table 47. Bespak Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Bespak Inhalation CDMO Product Portfolio Table 49. Bespak Recent Development Table 50. Catalent Company Information Table 51. Catalent Business Overview Table 52. Catalent Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Catalent Inhalation CDMO Product Portfolio Table 54. Catalent Recent Development Table 55. CritiTech Company Information Table 56. CritiTech Business Overview Table 57. CritiTech Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. CritiTech Inhalation CDMO Product Portfolio Table 59. CritiTech Recent Development Table 60. Enteris Biopharma Company Information Table 61. Enteris Biopharma Business Overview Table 62. Enteris Biopharma Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Enteris Biopharma Inhalation CDMO Product Portfolio Table 64. Enteris Biopharma Recent Development Table 65. Experic Company Information Table 66. Experic Business Overview Table 67. Experic Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Experic Inhalation CDMO Product Portfolio Table 69. Experic Recent Development Table 70. HCmed Company Information Table 71. HCmed Business Overview Table 72. HCmed Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. HCmed Inhalation CDMO Product Portfolio Table 74. HCmed Recent Development Table 75. Hovione Company Information Table 76. Hovione Business Overview Table 77. Hovione Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Hovione Inhalation CDMO Product Portfolio Table 79. Hovione Recent Development Table 80. Iconovo Company Information Table 81. Iconovo Business Overview Table 82. Iconovo Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Iconovo Inhalation CDMO Product Portfolio Table 84. Iconovo Recent Development Table 85. Kindeva Company Information Table 86. Kindeva Business Overview Table 87. Kindeva Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Kindeva Inhalation CDMO Product Portfolio Table 89. Kindeva Recent Development Table 90. Lonza Company Information Table 91. Lonza Business Overview Table 92. Lonza Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Lonza Inhalation CDMO Product Portfolio Table 94. Lonza Recent Development Table 95. Particle Sciences Company Information Table 96. Particle Sciences Business Overview Table 97. Particle Sciences Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Particle Sciences Inhalation CDMO Product Portfolio Table 99. Particle Sciences Recent Development Table 100. Proveris Company Information Table 101. Proveris Business Overview Table 102. Proveris Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Proveris Inhalation CDMO Product Portfolio Table 104. Proveris Recent Development Table 105. Recipharm Company Information Table 106. Recipharm Business Overview Table 107. Recipharm Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Recipharm Inhalation CDMO Product Portfolio Table 109. Recipharm Recent Development Table 110. Renejix Company Information Table 111. Renejix Business Overview Table 112. Renejix Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Renejix Inhalation CDMO Product Portfolio Table 114. Renejix Recent Development Table 115. Ritedose Company Information Table 116. Ritedose Business Overview Table 117. Ritedose Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Ritedose Inhalation CDMO Product Portfolio Table 119. Ritedose Recent Development Table 120. Vectura Company Information Table 121. Vectura Business Overview Table 122. Vectura Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Vectura Inhalation CDMO Product Portfolio Table 124. Vectura Recent Development Table 125. Sanner Company Information Table 126. Sanner Business Overview Table 127. Sanner Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Sanner Inhalation CDMO Product Portfolio Table 129. Sanner Recent Development Table 130. North America Inhalation CDMO Market Size by Type (2021-2026) & (US$ Million) Table 131. North America Inhalation CDMO Market Size by Type (2027-2032) & (US$ Million) Table 132. North America Inhalation CDMO Market Size by Application (2021-2026) & (US$ Million) Table 133. North America Inhalation CDMO Market Size by Application (2027-2032) & (US$ Million) Table 134. North America Inhalation CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Inhalation CDMO Market Size by Country (2021-2026) Table 136. North America Inhalation CDMO Market Size by Country (2027-2032) Table 137. Europe Inhalation CDMO Market Size by Type (2021-2026) & (US$ Million) Table 138. Europe Inhalation CDMO Market Size by Type (2027-2032) & (US$ Million) Table 139. Europe Inhalation CDMO Market Size by Application (2021-2026) & (US$ Million) Table 140. Europe Inhalation CDMO Market Size by Application (2027-2032) & (US$ Million) Table 141. Europe Inhalation CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Inhalation CDMO Market Size by Country (2021-2026) Table 143. Europe Inhalation CDMO Market Size by Country (2027-2032) Table 144. China Inhalation CDMO Market Size by Type (2021-2026) & (US$ Million) Table 145. China Inhalation CDMO Market Size by Type (2027-2032) & (US$ Million) Table 146. China Inhalation CDMO Market Size by Application (2021-2026) & (US$ Million) Table 147. China Inhalation CDMO Market Size by Application (2027-2032) & (US$ Million) Table 148. Asia Inhalation CDMO Market Size by Type (2021-2026) & (US$ Million) Table 149. Asia Inhalation CDMO Market Size by Type (2027-2032) & (US$ Million) Table 150. Asia Inhalation CDMO Market Size by Application (2021-2026) & (US$ Million) Table 151. Asia Inhalation CDMO Market Size by Application (2027-2032) & (US$ Million) Table 152. Asia Inhalation CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Asia Inhalation CDMO Market Size by Country (2021-2026) Table 154. Asia Inhalation CDMO Market Size by Country (2027-2032) Table 155. South America, Middle East & Africa Inhalation CDMO Market Size by Type (2021-2026) & (US$ Million) Table 156. South America, Middle East & Africa Inhalation CDMO Market Size by Type (2027-2032) & (US$ Million) Table 157. South America, Middle East & Africa Inhalation CDMO Market Size by Application (2021-2026) & (US$ Million) Table 158. South America, Middle East & Africa Inhalation CDMO Market Size by Application (2027-2032) & (US$ Million) Table 159. South America, Middle East & Africa Inhalation CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. South America, Middle East & Africa Inhalation CDMO Market Size by Country (2021-2026) Table 161. South America, Middle East & Africa Inhalation CDMO Market Size by Country (2027-2032) Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Inhalation CDMO Product Image Figure 2. Global Inhalation CDMO Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Inhalation CDMO Market Share by Type: 2025 VS 2032 Figure 4. Soft Mist Inhalers (SMIs) Image Figure 5. Dry Powder Inhalers (DPIs) Image Figure 6. Metered Dose Inhalers (MDIs) Image Figure 7. Others Image Figure 8. Global Inhalation CDMO Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Inhalation CDMO Market Share by Application: 2025 VS 2032 Figure 10. Commercial Image Figure 11. Academic Research Image Figure 12. Others Image Figure 13. Global Inhalation CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 15. Global Inhalation CDMO Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Inhalation CDMO Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Inhalation CDMO Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Inhalation CDMO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Inhalation CDMO Revenue Market Share by Type (2021-2032) Figure 22. Global Inhalation CDMO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Inhalation CDMO Revenue Market Share by Application (2021-2032) Figure 24. North America Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 25. North America Inhalation CDMO Market Share by Type (2021-2032) Figure 26. North America Inhalation CDMO Market Share by Application (2021-2032) Figure 27. North America Inhalation CDMO Market Share by Country (2021-2032) Figure 28. United States Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 29. Canada Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 31. Europe Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 32. Europe Inhalation CDMO Market Share by Type (2021-2032) Figure 33. Europe Inhalation CDMO Market Share by Application (2021-2032) Figure 34. Europe Inhalation CDMO Market Share by Country (2021-2032) Figure 35. Germany Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 36. France Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 38. Italy Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 39. Russia Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 41. China Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 42. China Inhalation CDMO Market Share by Type (2021-2032) Figure 43. China Inhalation CDMO Market Share by Application (2021-2032) Figure 44. Asia Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 45. Asia Inhalation CDMO Market Share by Type (2021-2032) Figure 46. Asia Inhalation CDMO Market Share by Application (2021-2032) Figure 47. Asia Inhalation CDMO Market Share by Country (2021-2032) Figure 48. Japan Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 52. India Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 53. Australia Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Inhalation CDMO Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Inhalation CDMO Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Inhalation CDMO Market Share by Country (2021-2032) Figure 58. Brazil Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 63. UAE Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 65. Chile Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Soft Mist Inhalers (SMIs)
  • Dry Powder Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Others
Applications
  • Commercial
  • Academic Research
  • Others
Companies covered
  • Aptar Pharma
  • Bend Bioscience
  • Bespak
  • Catalent
  • CritiTech
  • Enteris Biopharma
  • Experic
  • HCmed
  • Hovione
  • Iconovo
  • Kindeva
  • Lonza
  • Particle Sciences
  • Proveris
  • Recipharm
  • Renejix
  • Ritedose
  • Vectura
  • Sanner

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Inhalation CDMO Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Soft Mist Inhalers (SMIs)
  5. 1.2.3 Dry Powder Inhalers (DPIs)
  6. 1.2.4 Metered Dose Inhalers (MDIs)
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Inhalation CDMO Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Commercial
  11. 1.3.3 Academic Research
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Inhalation CDMO Growth Trends by Region
  15. 1.5.1 Global Inhalation CDMO Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Inhalation CDMO Market Size by Region (2021-2026)
  17. 1.5.3 Inhalation CDMO Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Inhalation CDMO Market Dynamics
  1. 2.1 Inhalation CDMO Industry Trends
  2. 2.2 Inhalation CDMO Industry Drivers
  3. 2.3 Inhalation CDMO Industry Opportunities and Challenges
  4. 2.4 Inhalation CDMO Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Inhalation CDMO Revenue by Company (2021-2026)
  2. 3.2 Global Inhalation CDMO Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Inhalation CDMO Key Company Head office and Area Served
  4. 3.4 Global Inhalation CDMO Company, Product Type & Application
  5. 3.5 Global Inhalation CDMO Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Inhalation CDMO Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Inhalation CDMO Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Inhalation CDMO Tier 1, Tier 2, and Tier 3
4 Inhalation CDMO Market by Type
  1. 4.1 Global Inhalation CDMO Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Inhalation CDMO Market Size by Type (2021-2032)
  3. 4.3 Global Inhalation CDMO Market Size Share by Type (2021-2032)
5 Inhalation CDMO Market by Application
  1. 5.1 Global Inhalation CDMO Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Inhalation CDMO Market Size by Application (2021-2032)
  3. 5.3 Global Inhalation CDMO Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Aptar Pharma
  2. 6.1.1 Aptar Pharma Company Information
  3. 6.1.2 Aptar Pharma Business Overview
  4. 6.1.3 Aptar Pharma Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Aptar Pharma Inhalation CDMO Product Portfolio
  6. 6.1.5 Aptar Pharma Recent Developments
  7. 6.2 Bend Bioscience
  8. 6.2.1 Bend Bioscience Company Information
  9. 6.2.2 Bend Bioscience Business Overview
  10. 6.2.3 Bend Bioscience Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Bend Bioscience Inhalation CDMO Product Portfolio
  12. 6.2.5 Bend Bioscience Recent Developments
  13. 6.3 Bespak
  14. 6.3.1 Bespak Company Information
  15. 6.3.2 Bespak Business Overview
  16. 6.3.3 Bespak Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bespak Inhalation CDMO Product Portfolio
  18. 6.3.5 Bespak Recent Developments
  19. 6.4 Catalent
  20. 6.4.1 Catalent Company Information
  21. 6.4.2 Catalent Business Overview
  22. 6.4.3 Catalent Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Catalent Inhalation CDMO Product Portfolio
  24. 6.4.5 Catalent Recent Developments
  25. 6.5 CritiTech
  26. 6.5.1 CritiTech Company Information
  27. 6.5.2 CritiTech Business Overview
  28. 6.5.3 CritiTech Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 CritiTech Inhalation CDMO Product Portfolio
  30. 6.5.5 CritiTech Recent Developments
  31. 6.6 Enteris Biopharma
  32. 6.6.1 Enteris Biopharma Company Information
  33. 6.6.2 Enteris Biopharma Business Overview
  34. 6.6.3 Enteris Biopharma Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Enteris Biopharma Inhalation CDMO Product Portfolio
  36. 6.6.5 Enteris Biopharma Recent Developments
  37. 6.7 Experic
  38. 6.7.1 Experic Company Information
  39. 6.7.2 Experic Business Overview
  40. 6.7.3 Experic Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Experic Inhalation CDMO Product Portfolio
  42. 6.7.5 Experic Recent Developments
  43. 6.8 HCmed
  44. 6.8.1 HCmed Company Information
  45. 6.8.2 HCmed Business Overview
  46. 6.8.3 HCmed Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 HCmed Inhalation CDMO Product Portfolio
  48. 6.8.5 HCmed Recent Developments
  49. 6.9 Hovione
  50. 6.9.1 Hovione Company Information
  51. 6.9.2 Hovione Business Overview
  52. 6.9.3 Hovione Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Hovione Inhalation CDMO Product Portfolio
  54. 6.9.5 Hovione Recent Developments
  55. 6.10 Iconovo
  56. 6.10.1 Iconovo Company Information
  57. 6.10.2 Iconovo Business Overview
  58. 6.10.3 Iconovo Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Iconovo Inhalation CDMO Product Portfolio
  60. 6.10.5 Iconovo Recent Developments
  61. 6.11 Kindeva
  62. 6.11.1 Kindeva Company Information
  63. 6.11.2 Kindeva Business Overview
  64. 6.11.3 Kindeva Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Kindeva Inhalation CDMO Product Portfolio
  66. 6.11.5 Kindeva Recent Developments
  67. 6.12 Lonza
  68. 6.12.1 Lonza Company Information
  69. 6.12.2 Lonza Business Overview
  70. 6.12.3 Lonza Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Lonza Inhalation CDMO Product Portfolio
  72. 6.12.5 Lonza Recent Developments
  73. 6.13 Particle Sciences
  74. 6.13.1 Particle Sciences Company Information
  75. 6.13.2 Particle Sciences Business Overview
  76. 6.13.3 Particle Sciences Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Particle Sciences Inhalation CDMO Product Portfolio
  78. 6.13.5 Particle Sciences Recent Developments
  79. 6.14 Proveris
  80. 6.14.1 Proveris Company Information
  81. 6.14.2 Proveris Business Overview
  82. 6.14.3 Proveris Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Proveris Inhalation CDMO Product Portfolio
  84. 6.14.5 Proveris Recent Developments
  85. 6.15 Recipharm
  86. 6.15.1 Recipharm Company Information
  87. 6.15.2 Recipharm Business Overview
  88. 6.15.3 Recipharm Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Recipharm Inhalation CDMO Product Portfolio
  90. 6.15.5 Recipharm Recent Developments
  91. 6.16 Renejix
  92. 6.16.1 Renejix Company Information
  93. 6.16.2 Renejix Business Overview
  94. 6.16.3 Renejix Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Renejix Inhalation CDMO Product Portfolio
  96. 6.16.5 Renejix Recent Developments
  97. 6.17 Ritedose
  98. 6.17.1 Ritedose Company Information
  99. 6.17.2 Ritedose Business Overview
  100. 6.17.3 Ritedose Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Ritedose Inhalation CDMO Product Portfolio
  102. 6.17.5 Ritedose Recent Developments
  103. 6.18 Vectura
  104. 6.18.1 Vectura Company Information
  105. 6.18.2 Vectura Business Overview
  106. 6.18.3 Vectura Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Vectura Inhalation CDMO Product Portfolio
  108. 6.18.5 Vectura Recent Developments
  109. 6.19 Sanner
  110. 6.19.1 Sanner Company Information
  111. 6.19.2 Sanner Business Overview
  112. 6.19.3 Sanner Inhalation CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Sanner Inhalation CDMO Product Portfolio
  114. 6.19.5 Sanner Recent Developments
7 North America
  1. 7.1 North America Inhalation CDMO Market Size (2021-2032)
  2. 7.2 North America Inhalation CDMO Market Size by Type
  3. 7.2.1 North America Inhalation CDMO Market Size by Type (2021-2026)
  4. 7.2.2 North America Inhalation CDMO Market Size by Type (2027-2032)
  5. 7.2.3 North America Inhalation CDMO Market Share by Type (2021-2032)
  6. 7.3 North America Inhalation CDMO Market Size by Application
  7. 7.3.1 North America Inhalation CDMO Market Size by Application (2021-2026)
  8. 7.3.2 North America Inhalation CDMO Market Size by Application (2027-2032)
  9. 7.3.3 North America Inhalation CDMO Market Share by Application (2021-2032)
  10. 7.4 North America Inhalation CDMO Market Size by Country
  11. 7.4.1 North America Inhalation CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Inhalation CDMO Market Size by Country (2021-2026)
  13. 7.4.3 North America Inhalation CDMO Market Size by Country (2027-2032)
  14. 7.4.4 North America Inhalation CDMO Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Inhalation CDMO Market Size (2021-2032)
  2. 8.2 Europe Inhalation CDMO Market Size by Type
  3. 8.2.1 Europe Inhalation CDMO Market Size by Type (2021-2026)
  4. 8.2.2 Europe Inhalation CDMO Market Size by Type (2027-2032)
  5. 8.2.3 Europe Inhalation CDMO Market Share by Type (2021-2032)
  6. 8.3 Europe Inhalation CDMO Market Size by Application
  7. 8.3.1 Europe Inhalation CDMO Market Size by Application (2021-2026)
  8. 8.3.2 Europe Inhalation CDMO Market Size by Application (2027-2032)
  9. 8.3.3 Europe Inhalation CDMO Market Share by Application (2021-2032)
  10. 8.4 Europe Inhalation CDMO Market Size by Country
  11. 8.4.1 Europe Inhalation CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Inhalation CDMO Market Size by Country (2021-2026)
  13. 8.4.3 Europe Inhalation CDMO Market Size by Country (2027-2032)
  14. 8.4.4 Europe Inhalation CDMO Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Inhalation CDMO Market Size (2021-2032)
  2. 9.2 China Inhalation CDMO Market Size by Type
  3. 9.2.1 China Inhalation CDMO Market Size by Type (2021-2026)
  4. 9.2.2 China Inhalation CDMO Market Size by Type (2027-2032)
  5. 9.2.3 China Inhalation CDMO Market Share by Type (2021-2032)
  6. 9.3 China Inhalation CDMO Market Size by Application
  7. 9.3.1 China Inhalation CDMO Market Size by Application (2021-2026)
  8. 9.3.2 China Inhalation CDMO Market Size by Application (2027-2032)
  9. 9.3.3 China Inhalation CDMO Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Inhalation CDMO Market Size (2021-2032)
  2. 10.2 Asia Inhalation CDMO Market Size by Type
  3. 10.2.1 Asia Inhalation CDMO Market Size by Type (2021-2026)
  4. 10.2.2 Asia Inhalation CDMO Market Size by Type (2027-2032)
  5. 10.2.3 Asia Inhalation CDMO Market Share by Type (2021-2032)
  6. 10.3 Asia Inhalation CDMO Market Size by Application
  7. 10.3.1 Asia Inhalation CDMO Market Size by Application (2021-2026)
  8. 10.3.2 Asia Inhalation CDMO Market Size by Application (2027-2032)
  9. 10.3.3 Asia Inhalation CDMO Market Share by Application (2021-2032)
  10. 10.4 Asia Inhalation CDMO Market Size by Country
  11. 10.4.1 Asia Inhalation CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Inhalation CDMO Market Size by Country (2021-2026)
  13. 10.4.3 Asia Inhalation CDMO Market Size by Country (2027-2032)
  14. 10.4.4 Asia Inhalation CDMO Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Inhalation CDMO Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Inhalation CDMO Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Inhalation CDMO Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Inhalation CDMO Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Inhalation CDMO Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Inhalation CDMO Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Inhalation CDMO Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Inhalation CDMO Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Inhalation CDMO Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Inhalation CDMO Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Inhalation CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Inhalation CDMO Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Inhalation CDMO Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Inhalation CDMO Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst